| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biocryst Pharmaceuticals Inc (BCRX) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. BCRX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.32M | $11.41M | - | |
| Other | 398.8K | $3.44M | - | |
| CFO | 268.7K | $2.32M | - | |
| Dir | 135.4K | $1.17M | - | |
| Dir | 99.1K | $854.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14, 2023 | Hutson Nancy J58 | Director | Sell | 12,866 | $8.04 | $103,442.64 | -13.6% | -12.6% | -21.5% | |
| Apr 3, 2023 | Thackray Helen M.78 | Chief R&D Officer | Sell | 7,000 | $8.29 | $58,030.00 | -3.3% | -15.8% | -44.0% | |
| Feb 1, 2023 | Stonehouse Jon P80 | President &CEO | Sale+OE | 100,000 | $10.38 | $1,038,000.00 | -9.0% | -29.9% | -49.8% | |
| Dec 15, 2022 | Stonehouse Jon P80 | President &CEO | Sell | 14,100 | $10.90 | $153,690.00 | -1.6% | -22.6% | -42.7% | |
| Dec 15, 2022 | Thackray Helen M.78 | Chief R&D Officer | Sell | 3,125 | $10.89 | $34,031.25 | -2.3% | -22.6% | -42.7% | |
| Dec 15, 2022 | Doyle Anthony70 | Chief Financial Officer | Sell | 5,700 | $10.90 | $62,130.00 | -3.4% | -22.6% | -42.7% | |
| Dec 15, 2022 | Gayer Charles K | Chief Commercial Officer | Sell | 6,100 | $10.90 | $66,490.00 | -2.8% | -22.6% | -42.7% | |
| Dec 15, 2022 | Jones Michael L74 | Exec. Director, Finance - Pao | Sell | 445 | $10.90 | $4,850.50 | -4.0% | -22.6% | -42.7% | |
| Dec 15, 2022 | Barnes Alane P70 | Chief Legal Officer | Sell | 4,175 | $10.88 | $45,424.00 | -2.1% | -22.6% | -42.7% | |
| Dec 2, 2022 | Stonehouse Jon P80 | President &CEO | Sale+OE | 297,573 | $12.94 | $3,851,917.80 | -14.2% | -30.7% | -51.9% |